FSTL1 and breast cancer: For example, FSTL1 (Follistatin Like 1) could increase breast cancer proliferation and stem cell marker expression, and it is closely associated with doxorubicin (DOX) and cisplatin (CDP) chemoresistance in breast cancer cells.